June 7, 2016 Glenn Roberts Jr., Lawrence Berkeley National Laboratory
Credit: NASA/CXC/M.Markevitch et al.; optical image by NASA/STScI, Magellan/U.Arizona/D.Clowe et al.; lensing map image by NASA/STScI, ESO WFI, Magellan/U.Arizona/D.Clowe et al.
A composite image of the “bullet cluster,” a galaxy cluster formed by a collision of two clusters. The pink clumps show hot gas containing most of the normal matter, while the two blue clumps reveal where most of the mass in the clusters is actually contained. This provides evidence for dark matter since most of the mass was expected to be concentrated around the pink areas.
What’s known
1. We can observe its effects.
While we can’t see dark matter, we can observe and measure its gravitational effects. Galaxies have been observed to spin much faster than expected based on their visible matter, and galaxies move faster in clusters than expected, too, so scientists can calculate the “missing mass” responsible for this motion.
2. It is abundant.
It makes up about 85 percent of the total mass of the universe, and about 27 percent of the universe’s total mass and energy.
3. We know more about what dark matter is not.
Increasingly sensitive detectors are lowering the possible rate at which dark mark matter particles can interact with normal matter.
What’s unknown
1. Is it made up of one particle or many particles?
Could dark matter be composed of an entire family of particles, such as a theorized “hidden valley” or “dark sector?”
2. Are there “dark forces” acting on dark matter?
Are there forces beyond gravity and other known forces that act on dark matter but not on ordinary matter, and can dark matter interact with itself?
3. Is there dark antimatter?
Could dark matter have an antimatter counterpart, as does normal matter, and is there a similar imbalance that favored dark matter over “dark antimatter” as with normal matter-antimatter?
Looking to curl up with some winter reads? Whether your taste leans toward coming-of-age memoir or non-fiction, cooking or crime, we have something for you.
Research from UC San Diego explains the clinical failure of dozens of candidate vaccines for one of the most common human infections; it also suggests a way to fix the problem.